Natixis Advisors, L.P. Abiomed Inc Transaction History

Natixis Advisors, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$277.25 - $366.29 $3.47 Million - $4.59 Million	-12,527 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$300.63 - $371.35 $166,549 - $205,727	554 Added 4.63%	12,527 $4.5 Million
Q3 2021 Nov 15, 2021	BUY	$310.19 - $376.2 $261,179 - $316,760	842 Added 7.56%	11,973 $3.9 Million
Q2 2021 Aug 12, 2021	BUY	$262.71 - $351.17 $101,931 - $136,253	388 Added 3.61%	11,131 $3.47 Million
Q1 2021 May 05, 2021	SELL	$285.92 - $355.13 $293,068 - $364,008	-1,025 Reduced 8.71%	10,743 $3.42 Million
Q4 2020 Feb 12, 2021	BUY	$251.88 - $324.2 $2.96 Million - $3.82 Million	11,768 New	11,768 $3.82 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

Stay updated on Natixis Advisors, L.P. with notifications on news.